B
Next Generation Transformation
Since June 2024, BPP GmbH is accepting (pre-)orders for our newest proprietary gene delivery technology at the introductory price.
BPP Bioportide™ are peptide-based transformation/transfection agents that actively transport nucleic acids, i.e. DNA and RNA, across the plasma membrane of a wide range of host cells and cell types. This achieved using specialized cell-penetrating peptide moieties that are able to sponantously insert into biomembranes.
We contantly test, improve and expand our repertoire of BPP Bioportide™ variants and plan to offer various transformation/transfection kits in the future.
The start makes BPP Bioportide™ BP17, which has shown excellent results in gram-negative bacteria, in particular E. coli.
For more information, please follow the link below.
Figure | Mock-up of our new BPP Bioportide™ Kit for bacterial transformation.
From our and our scientific partners' studies, it becomes clear that BPP Bioportide™ are capable of transforming and transfecting a wide range of model organisms from various domains of life, showing particularly interesting results not only in bacteria (e.g. Steptomyces) but also lower and higher eukaryotes (e.g. yeast and plants). For this reason, we have put together a test kit comprising 10 of our most potent BPP Bioportide™ variants for you to transform your model organism of choice. Find which BPP Bioportide™ is working best for you, we are looking forward to supporting you in your research. Learning from one another, we hope to accelerate research and find tailored solutions in gene delivery.
Badische Peptide und Proteine GmbH is funded as part of the Baden-Württemberg state strategy for a sustainable bioeconomy.